Amador Bioscience Welcomes Dr. Lorin Roskos as Chief Scientific Officer and President of Quantitative Clinical Pharmacology

PLEASANTON, Calif., May 5, 2023 /PRNewswire/ — Amador Bioscience, a full-service CRO with global expertise in translational research and clinical development, has announced the appointment of Dr. Lorin Roskos as Chief Scientific Officer (CSO) and President of Quantitative Clinical…